Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 444 of 6351
-
New combo targets genetic weakness in tough pancreatic cancer
Disease control Recruiting nowThis is a Phase 2 trial evaluating the combination of cemiplimab with the standard of care chemotherapy agent gemcitabine for the treatment of patients with metastatic pancreatic ductal adenocarcinoma with SWItch/Sucrose Non-Fermentable (SWI/SNF) alterations who have already been…
Phase 2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Double defense against RSV: could Mom's vaccine plus Baby's shot be the key?
Prevention Recruiting nowRSV (which stands for Respiratory Syncytial Virus) is an infection that causes cold-like symptoms and is most common during winter months. Most people with RSV infection get better by themselves but babies and younger children can become very poorly. About 1 in 15 infants with co…
Phase 3 • Sponsor: Centre Hospitalier Annecy Genevois • Aim: Prevention
Last updated Jun 27, 2026 12:38 UTC
-
Can a blood test guide better cancer treatment after surgery?
Disease control Not yet recruitingThis study was a multicenter, randomized, phase 3 trial to determine whether adjuvant chemotherapy including tisleliizumab improves recurrence-free survival compared to follow-up alone without chemotherapy in patients with curatively resected esophageal squamous cell carcinoma.
Phase 3 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for heart patients with brain bleed history: catheter ablation vs. standard care
Disease control Recruiting nowSAFER-AF is an investigator-initiated, multicenter, open-label, parallel-group trial comparing catheter ablation versus usual care in patients with atrial fibrillation and intracranial hemorrhage.
Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Second chance: new stroke treatment could save more brain tissue
Disease control Recruiting nowIschemic cerebrovascular disease is a common neurological disorder with high incidence, mortality, and disability. Early reperfusion to salvage the ischemic penumbra is the cornerstone of acute ischemic stroke (AIS) treatment. Current reperfusion strategies include intravenous th…
Phase 2 • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Simple dental exam before heart surgery may prevent deadly infections
Prevention Recruiting nowThis randomized, multicenter, open-label trial evaluates whether preoperative dental screening improves outcomes in patients undergoing surgical or transcatheter cardiac valve intervention. Participants are randomized 1:1 to preoperative dental screening or no screening. The prim…
Sponsor: Region Skane • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
AI could spot breast cancer on routine chest CTs, no extra test needed
Diagnosis Recruiting nowThe goal of this observational study is to evaluate the feasibility and effectiveness of using non-contrast chest computed tomography scans for opportunistic breast cancer screening, and to further compare its diagnostic performance with conventional imaging modalities, including…
Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
AI takes on lymphoma: personalized treatment strategy under trial
Disease control Not yet recruitingThis is a prospective, open-label, multicenter, randomized controlled study in participants with previously untreated large B-cell lymphoma. Participants will be stratified into different risk groups using an AI-based multimodal model. Those classified as intermediate- or high-ri…
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a blood vessel drug beat aspirin at preventing heart attacks in diabetes?
Prevention Recruiting nowPatients with type 2 diabetes and cardiovascular risk factors are at increased risk of cardiovascular events. Therefore, a multi-center prospective randomized study will be conducted to compare the efficacy and safety of cilostazol and aspirin for the prevention of major adverse …
Phase 4 • Sponsor: Seoul National University Bundang Hospital • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Ear-Zapping device may tame social anxiety — trial puts it to the test
Symptom relief Recruiting nowThis clinical trial aims to evaluate the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with social anxiety disorder (SAD). The study addresses the following key research questions: * Does taVNS demonstrate preliminary clinical effica…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
A simple conversation bundle might curb the global rise in c-sections
Disease control Recruiting nowCesarean section (CS) rates have rapidly increased worldwide, with projections suggesting that by 2030, one in every three births will be by CS (1). In Sweden, rates have more than doubled from 9% in the 1990s, to 20% in 2024 (2). While CS can be a life-saving procedure when medi…
Sponsor: Lund University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New weekly shot could help sleep apnea without CPAP
Disease control Recruiting nowThis study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not treated with positive airway pressure lose weight and improve sleep apnoea. There are 2 study treatments in this study taken as inj…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New weekly shot could help sleep apnea and weight loss
Disease control Recruiting nowThis study is being done to look at the efficacy and safety of NNC0487-0111 in participants with overweight or obesity, and obstructive sleep apnoea treated with positive airway pressure. There are 2 study treatments in this study taken as injections under the skin once a week. P…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 10, 2026 08:00 UTC
-
Shock therapy for BPH: new electrical ablation may spare sex life
Disease control Not yet recruitingThe study aims to find a better surgical treatment for men with an enlarged prostate (Benign Prostatic Hyperplasia, or BPH) that effectively relieves urinary symptoms without sacrificing sexual function. Currently, standard surgeries like TURP or HoLEP are very effective at open…
Sponsor: Shanghai East Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
AI vs. expert eyes: a new test for heart function measurement
Diagnosis OngoingThe purpose of this study is to validate the efficacy of Kosmos PLAX EF, an AI-assisted workflow that uses a cardiac ultrasound clip in Parasternal Long Axis (PLAX) cardiac view to calculate Left Ventricular Ejection Fraction (LVEF) using the Teichholz method. This study will com…
Sponsor: EchoNous Inc. • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
New hope for glioblastoma? drug combo trial targets aggressive brain tumors
Disease control Recruiting nowThe purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) better than using temozolomide alone in the maintenance setting. Specifically, this study is being done to find answers t…
Phase 2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug aims to keep leukemia at bay after first treatment
Disease control Recruiting nowThe purpose of this study is to evaluate the therapeutic benefit and safety of subcutaneous (SC) Surovatamig monotherapy as consolidation therapy in patients with Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) with unmutated IGHV (uIGHV).
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug cocktail aims to stop head and neck cancer return
Disease control Not yet recruitingA multicenter, randomized, controlled, open-label, Phase II/III clinical trial designed to evaluate the efficacy and safety of postoperative radiotherapy combined with Nimotuzumab,with or without Bemcentinib, in postoperative head and neck squamouscell cancer patients with interm…
Phase 2/3 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Stem cell transplant offers new hope for rare immune diseases
Disease control Recruiting nowThis is a research protocol that will examine Hematopoietic Stem Cell Transplantation (HSCT) using a reduced conditioning regimen (RIC) with total body Irradiation (TBI) in those diagnosed with Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary…
Phase 2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New online therapy aims to ease PTSD after sexual abuse
Symptom relief Recruiting nowThis project aims to evaluate Restory - a newly developed anonymous, iCBT prolonged exposure therapy program specifically tailored for victims of sexual abuse - using a pre-registered randomized controlled trial with waitlist control. The primary research question is whether Rest…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC